Intranasal Fentanyl
Intranasal Fentanyl is a pharmaceutical formulation of the synthetic opioid fentanyl administered via the nasal route, distinguished by its rapid absorption through the nasal mucosa to provide fast-acting analgesia for the management of breakthrough cancer pain.
169
Publications
7.5K
Citations
749
Authors
315
Institutions
Publications per year
2017–2026
43
Parents
169
Sebastiano Mercadante, Lukas Radbruch, Andrew Davies et al. · Current Medical Research and Opinion · 2009 · 164 citations
Claire M. Rickard, Peter O’Meara, Matthew McGrail et al. · The American Journal of Emergency Medicine · 2007 · 158 citations · Full text
1–5 of 169
749
6
h-index
6
h-index
4
h-index
4
h-index
4
h-index
1–5 of 749
315

The University of Western Australia
Perth, Australia
8 h-index
10 publications
1.2K citations

Princess Margaret Hospital for Children
Perth, Australia
7 h-index
19 publications
1.9K citations
Norwegian University of Science and Technology
Trondheim, Norway
5 h-index
14 publications
648 citations
NSW Ambulance
Sydney Olympic Park, Australia
5 h-index
16 publications
1.2K citations
University of Utah
Salt Lake City, United States
5 h-index
17 publications
1K citations

Royal Children's Hospital
Melbourne, Australia
5 h-index
9 publications
461 citations
Baylor College of Medicine
Houston, United States
4 h-index
6 publications
155 citations
La Maddalena
Palermo, Italy
4 h-index
9 publications
419 citations
1–8 of 315
AJEM · 10 publications · 422 citations
10
h-index
7 publications · 315 citations
7
h-index
5 publications · 120 citations
5
h-index
5 publications · 327 citations
5
h-index
5 publications · 330 citations
5
h-index
1–5